Amritsar Online

Asthma Therapies, Key Companies and Pipeline Landscape Analysis by DelveInsight

 Breaking News
  • No posts were found

Asthma Therapies, Key Companies and Pipeline Landscape Analysis by DelveInsight

December 15
20:36 2021
Asthma Therapies, Key Companies and Pipeline Landscape Analysis by DelveInsight
Asthma Pipeline
There are currently 100+ companies working in the Asthma pipeline landscape.

DelveInsight’s Asthma pipeline report provides comprehensive coverage of the emerging drugs profiles, including clinical and nonclinical products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type.

Key Takeaways from the Asthma Pipeline Report

  • There are currently 100+ drugs in the Asthma pipeline.
  • The Asthma pipeline consists of therapies in different clinical phase stages, including Depemokimab, FB704A, MEDI 3506, AQ001S, MRx-4DP0004, SHR-1703, and others.
  • Leading companies actively working to improve the Asthma treatment landscape are GlaxoSmithKline, Oneness Biotech, AstraZeneca, Aquilon Pharma, 4D Pharma PLC, Jiangsu Hengrui Medicine, and others.
  • Key Asthma pipeline therapies in the late stage of development include Depemokimab (GlaxoSmithKline), FB704A (Oneness Biotech), MEDI 3506 (AstraZeneca), and others.
  • SHR-1703 is being developed and evaluated in the phase 1 Asthma clinical trials by Jiangsu Hengrui Medicine.

Get a detailed analysis of the pipeline landscape @ Asthma Pipeline Analysis

Asthma Overview

Asthma is a chronic disease that affects the airways, also known as the bronchial tubes. It is a diverse disease with episodes of airway narrowing or hyperresponsiveness, obstruction, inflammation, and mucous production. The narrowing of the airways causes shortness of breath and coughing. Different inflammatory pathways are responsible for the airway inflammation and hyperresponsiveness associated with asthma.

Asthma Symptoms 

Asthma symptoms can vary from person to person. However, the most common asthma symptoms are shortness of breath, wheezing, coughing, and chest tightness. Over time, these symptoms can progress from mild to severe. Asthma symptoms can worsen and cause asthma attacks in some people.

Asthma Treatment

Asthma currently has no cure or specific treatment, but medication and lifestyle changes can help relieve symptoms. Long-term control treatments for asthma, such as inhaled corticosteroids, long-acting beta-agonists, and oral medications, are currently available. Oral corticosteroids, beta-agonists, and inhaled bronchodilators are used to treat acute episodes.

Asthma Pipeline Analysis: Drug Profiles

Depemokimab: GlaxoSmithKline

Product Description

Depemokimab, an Interleukin 5 receptor antagonist monoclonal antibody currently in development by GlaxoSmithKline, is being developed to treat severe asthma with an eosinophilic phenotype.

Phase III

NCT04719832: GlaxoSmithKline initiated a Phase III, 52-week, randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the efficacy and safety of gsk3511294 adjunctive therapy in adults and adolescents with severe uncontrolled asthma with an eosinophilic phenotype in March 2021. gsk3511294 (depemokimab) is being developed as a long-acting (la) injectable anti-interleukin-5 (anti-il-5) therapy with an efficacy and safety profile comparable to current anti-il-5 therapies but with a lower dosing frequency.

Asthma Pipeline Therapies and Key Companies

  • Depemokimab: GlaxoSmithKline
  • FB704A: , and asthmaOneness Biotech
  • MEDI 3506: AstraZeneca
  • AQ001S: Aquilon Pharma
  • MRx-4DP0004: 4D Pharma PLC
  • SHR-1703: Jiangsu Hengrui Medicine

Find out the emerging therapies and companies @ Asthma Clinical Trials

Asthma Therapeutics Assessment

  • By Product Type
    • Monotherapy
    • Combination Therapy
  • By Stage
    • Discovery
    • Pre-Clinical
    • Phase I
    • Phase II
    • Phase III
    • Pre-registration
  • By Route of Administration
    • Inhalation
    • Intravenous
    • Oral
    • Subcutaneous
  • By Molecule Type
    • Small Molecule
    • Stem Cell Therapy
    • Gene Therapy
  • Targets
    • Immune System
    • Multiple Kinase
  • By Mechanism of Action
    • Protease Inhibitors
    • Immunomodulatory

Scope of the Report

Coverage: Global

Asthma Key Players: GlaxoSmithKline, Oneness Biotech, AstraZeneca, Aquilon Pharma, 4D Pharma PLC, Jiangsu Hengrui Medicine, among others

Asthma Pipeline Therapies: Depemokimab, FB704A, MEDI 3506, AQ001S, MRx-4DP0004, SHR-1703, and others

Table of Contents 




Executive Summary


Asthma: Overview


Asthma Analytical Perspective In-depth Commercial Assessment


Pipeline Therapeutics


Late Stage Products (Registered)


Late Stage Products (Phase  III)


Mid Stage Products (Phase  II)


Early Stage Products (Phase  I/II)


Early-stage Products (Phase 1)


Therapeutic Assessment


Inactive Products


Company-University Collaborations (Licensing/Partnering) Analysis


Asthma Key Companies


Asthma Key Products


Asthma Unmet Needs


Asthma Market Drivers and Barriers


Asthma Future Perspectives and Conclusion


Asthma Analyst Views




About DelveInsight

Get in touch with our business executive for Healthcare Due Diligence Services

Key questions answered in the Asthma Pipeline Report

  • What are Asthma treatments available?
  • How are many pharmaceutical companies developing asthma treatments?
  • Which of these companies’ pharmaceuticals is the most commonly used?
  • How many Asthma medications are manufactured by each company?
  • How many asthma drugs are in the early, mid, or late stages of development?
  • How many of the currently being developed therapies can be used alone or in combination with other treatments?
  • What are the critical Asthma collaborations, mergers and acquisitions, and licensing practices?

Related Reports

Asthma Diagnostic Devices Market

Get a comprehensive analysis of Asthma Diagnostic Devices pipeline devices and key companies, including Medline Industries, Inc., Becton, Dickinson and Company, Siemens Process Instrumentation, Smiths Medical, Vyaire Medical, Inc., Nihon Kohden Corporation, Vitalograph, Circassia Limited, among others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States

Related Articles